US$ 24.78
livea glp 1 | Physician-Led Weight Loss | Happy #FeelGoodFriday from Livea! Check out our latest episode of Beyond the Scale with our friends, Ben Leber & Elizabeth Ries, on Twin Livea - Medical Weight Loss
Description
Mendelsohn lays out why Vivani shifted from a broad platform story to focusing 90% of the company on a GLP-1 drugdevice product, how theyre using the 505(b)(2) pathway to shorten development by leveraging existing semaglutide data, and why the ability to stop treatment by removing the implant addresses a limitation of long-acting injectables

this week

Over the last year, the Indian obesity-treatment market has changed very fast
Discover common gauge and length options (30G-32G) for a painless experience.

The once hard-to-get prescription drug is now widely...

Meal-Replacement Shakes
